New search Hide text from Guidelines
N NERVOUS SYSTEMN04 ANTI-PARKINSON DRUGS
This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.
| The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease. No separate DDDs are established for oral depot formulations. |
N04B DOPAMINERGIC AGENTS
N04BD Monoamine oxidase B inhibitors
| ATC code | Name | DDD | U | Adm.R | Note |
| N04BD01 | selegiline | 5 | mg | O | |
| N04BD02 | rasagiline | 1 | mg | O | |
| N04BD03 | safinamide | 75 | mg | O |
Last updated: 2024-01-26